Literature DB >> 10551662

Predictors of time to completion of the hepatitis B vaccination series among adolescents.

A B Middleman1, L M Robertson, C Young, R H Durant, S J Emans.   

Abstract

OBJECTIVES: To determine adolescents' completion rates and factors affecting completion time of hepatitis B (HBV) vaccination.
METHODS: Prior to vaccination, participants from a hospital-based and school-based adolescent clinic completed questionnaires assessing sociodemographic variables, family/friend experience with HBV and the vaccine, likelihood of completing the vaccinations, HBV and vaccine knowledge, risk behaviors, chronic illness, and access to clinic. Vaccination times were recorded.
RESULTS: Twenty-six months after initiation of the study, 72% of 896 eligible participants had completed the vaccination series. The independent predictors of shorter time to completion were: higher estimated mean household income [odds ratio (OR) = 1.15, 95% confidence interval (CI) = 1.06-1.25), white race (OR = 1.27, 95% CI = 1.01-1.58), female gender (OR = 1.58, 95% CI = 1.31-1.92], and not having smoked cigarettes (OR for smoking in the past 30 days = 0.74, 95% CI = 0.60-0.92). Site of care, risk factors for acquiring HBV, disease and vaccine knowledge, and self-reported desire to complete the series were not associated with completion time.
CONCLUSIONS: The primary factors associated with completion of immunization may not be amenable to intervention; mandated strategies for immunization may be more likely to result in protection for adolescents.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10551662     DOI: 10.1016/s1054-139x(99)00063-4

Source DB:  PubMed          Journal:  J Adolesc Health        ISSN: 1054-139X            Impact factor:   5.012


  12 in total

1.  Trends in vaccine-induced immunity to hepatitis B among Canadian street-involved youth.

Authors:  Ling Huang; Marie-Line Gilbert; Miriam F Rossi; David Haase; Judith Wright; Nadine Sicard; Carole Beaudoin; Darlene Taylor; Jennifer Gratrix; Lisa Belzak; Tom Wong; Gayatri Jayaraman
Journal:  J Urban Health       Date:  2010-02-20       Impact factor: 3.671

2.  Compliance with multiple-dose vaccine schedules among older children, adolescents, and adults: results from a vaccine safety datalink study.

Authors:  Jennifer C Nelson; Rachel C L Bittner; Lora Bounds; Shanshan Zhao; James Baggs; James G Donahue; Simon J Hambidge; Steven J Jacobsen; Nicola P Klein; Allison L Naleway; Kenneth M Zangwill; Lisa A Jackson
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  The nurse's role in preventing cervical cancer: A cultural framework.

Authors:  Versie Johnson-Mallard; Tami L Thomas; Elizabeth A Kostas-Polston; Michelle Barta; Cecile A Lengacher; Desiree Rivers
Journal:  Am Nurse Today       Date:  2012-07-01

4.  How can we communicate about vaccines with adolescents and their parents?

Authors:  Andrea L Benin; Ann C Wu; Eric S Holmboe; Eugene D Shapiro; Walter Anyan
Journal:  Clin Pediatr (Phila)       Date:  2010-01-28       Impact factor: 1.168

5.  Randomized trial to determine safety and immunogenicity of two strategies for hepatitis B vaccination in healthy urban adolescents in the United States.

Authors:  Coleen K Cunningham; Bret J Rudy; Jiahong Xu; James Bethel; Bill G Kapogiannis; Sushma Ahmad; Craig M Wilson; Patricia M Flynn
Journal:  Pediatr Infect Dis J       Date:  2010-06       Impact factor: 2.129

6.  Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses.

Authors:  Lea E Widdice; David I Bernstein; Anthony C Leonard; Keith A Marsolo; Jessica A Kahn
Journal:  Pediatrics       Date:  2010-12-13       Impact factor: 7.124

7.  The Impact of Gender Differences in Attitudes and Beliefs Concerning HBV Vaccination and Screening in the Lao Community.

Authors:  Odichinma Akosionu; Beth Virnig; Kathleen T Call; Jian-Min Yuan; Sunny Chanthanouvong; Ruby H N Nguyen
Journal:  J Immigr Minor Health       Date:  2016-02

8.  Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study.

Authors:  Pierre Van Damme; Anna Moiseeva; Igor Marichev; Anne-Diane Kervyn; Robert Booy; Sherine Kuriyakose; Andrew Brockway; Su-Peing Ng; Maarten Leyssen; Jeanne-Marie Jacquet
Journal:  BMC Infect Dis       Date:  2010-12-20       Impact factor: 3.090

9.  Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model.

Authors:  Eva Lefevere; Niel Hens; Frank De Smet; Pierre Van Damme
Journal:  BMC Public Health       Date:  2011-06-14       Impact factor: 3.295

10.  Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality.

Authors:  Suchita A Lorick; Daniel Fishbein; Eric Weintraub; Pascale M Wortley; Grace M Lee; Fangjun Zhou; Robert Davis
Journal:  BMC Infect Dis       Date:  2009-11-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.